Rachel Rowlinson has over 20 years experience in the pharmaceutical industry, working primarily in protein analysis including N-terminal sequencing and protein mass spectrometry.  Rachel spent the majority of her career at AstraZeneca where she was involved with drug discovery projects covering many research areas whilst in the Proteomics and Biological Mass Spec Groups.  She has a wealth of experience in proteomics analysis and protein mass spectrometry.   Rachel joined Peak Proteins 2 years ago as the Protein Mass Spectrometry Specialist where she runs the protein mass spectrometry service.